| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| uniQure N.V. | Director | Ordinary Shares | 29.9K | $433K | $14.45 | Jun 20, 2025 | Direct |
| Fulgent Genetics, Inc. | Director | Common Stock | 8K | $214K | $26.69 | Aug 1, 2022 | Direct |
| CG Oncology, Inc. | Director | Common Stock | 0 | $0 | $41.43 | Nov 17, 2025 | Direct |
| CG Oncology, Inc. | Director | Stock Option | 133K | Dec 16, 2024 | Direct | ||
| CG Oncology, Inc. | Director | Director Stock Option (right to buy) | 117K | Nov 17, 2025 | Direct | ||
| uniQure N.V. | Director | Stock Option (Right to Buy) | 15.6K | Jun 11, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | Nov 17, 2025 | 3 | -$40.8K | 4 | Nov 18, 2025 | Director |
| CGON | CG Oncology, Inc. | Oct 13, 2025 | 3 | -$42.7K | 4 | Oct 15, 2025 | Director |
| CGON | CG Oncology, Inc. | Sep 30, 2025 | 3 | -$197K | 4 | Oct 1, 2025 | Director |
| CGON | CG Oncology, Inc. | Sep 15, 2025 | 3 | -$34.5K | 4 | Sep 16, 2025 | Director |
| CGON | CG Oncology, Inc. | Sep 3, 2025 | 3 | -$27.4K | 4 | Sep 4, 2025 | Director |
| CGON | CG Oncology, Inc. | Jul 17, 2025 | 3 | -$54.8K | 4 | Jul 18, 2025 | Director |
| QURE | uniQure N.V. | Jun 20, 2025 | 1 | -$30.5K | 4 | Jun 24, 2025 | Director |
| QURE | uniQure N.V. | Jun 11, 2025 | 2 | $0 | 4 | Jun 13, 2025 | Director |
| CGON | CG Oncology, Inc. | Jun 5, 2025 | 1 | $0 | 4 | Jun 6, 2025 | Director |
| CGON | CG Oncology, Inc. | May 21, 2025 | 3 | -$27.4K | 4 | May 22, 2025 | Director |
| CGON | CG Oncology, Inc. | Apr 28, 2025 | 3 | -$30.2K | 4 | Apr 29, 2025 | Director |
| CGON | CG Oncology, Inc. | Mar 17, 2025 | 3 | -$27.4K | 4 | Mar 18, 2025 | Director |
| CGON | CG Oncology, Inc. | Feb 18, 2025 | 3 | -$28K | 4 | Feb 19, 2025 | Director |
| CGON | CG Oncology, Inc. | Jan 13, 2025 | 3 | -$29.1K | 4 | Jan 14, 2025 | Director |
| CGON | CG Oncology, Inc. | Dec 16, 2024 | 3 | -$28.2K | 4 | Dec 17, 2024 | Director |
| CGON | CG Oncology, Inc. | Dec 6, 2024 | 4 | -$33.9K | 4 | Dec 6, 2024 | Director |
| CGON | CG Oncology, Inc. | Oct 4, 2024 | 1 | $0 | 4 | Oct 7, 2024 | Director |
| QURE | uniQure N.V. | Jun 19, 2024 | 2 | $0 | 4 | Jun 21, 2024 | Director |
| QURE | uniQure N.V. | Jun 13, 2024 | 1 | -$11.4K | 4 | Jun 18, 2024 | Director |
| CGON | CG Oncology, Inc. | Jan 24, 2024 | 0 | $0 | 3 | Jan 24, 2024 | Director |
| QURE | uniQure N.V. | Jun 13, 2023 | 3 | -$43.1K | 4 | Jun 20, 2023 | Director |
| QURE | uniQure N.V. | Feb 27, 2023 | 1 | -$7.67K | 4 | Mar 1, 2023 | Director |
| FLGT | Fulgent Genetics, Inc. | Aug 1, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
| FLGT | Fulgent Genetics, Inc. | Aug 1, 2022 | 0 | $0 | 3 | Aug 3, 2022 | Director |
| QURE | uniQure N.V. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| QURE | uniQure N.V. | Feb 28, 2022 | 1 | -$13.2K | 4 | Mar 2, 2022 | Director |
| QURE | uniQure N.V. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | Director |